The galanin and galanin receptor subtypes, its regulatory role in the biological and pathological functions

Title:

The galanin and galanin receptor subtypes, its regulatory role in the biological and pathological functions

Creator:

Šípková, J., Kramáriková, I., Hynie, S., and Klenerová, V.

Identifier:

https://cdk.lib.cas.cz/client/handle/uuid:92eabf13-ab35-4fa9-9828-76dbc3ba61d7
uuid:92eabf13-ab35-4fa9-9828-76dbc3ba61d7

Subject:

galanin, galanin receptor, neurotransmission, galaninergic system, and regulatory function

Type:

article, model:article, and TEXT

Description:

The multitalented neuropeptide galanin was first discovered 30 years ago but initially no biologic activity was found. Further research studies discovered the presence of galanin in the brain and some peripheral tissues, and galanin was identified as a modulator of neurotransmission in the central and peripheral nervous system. Over the last decade there were performed very intensive studies of the neuronal actions and also of nonneuronal actions of galanin. Other galanin family peptides have been described, namely galanin, galanin-like peptide, galanin-message associated peptide and alarin. The effect of these peptides is mediated through three galanin receptors subtypes, GalR1, GalR2 and GalR3 belonging to G protein coupled receptors, and signaling via multiple transduction pathways, including inhibition of cyclic AMP/protein kinase A (GalR1, GalR3) and stimulation of phospholipase C (GalR2). This also explains why one specific molecule of galanin can be responsible for different roles in different tissues. The present review summarizes the information currently available on the relationship between the galaninergic system and known pathological states. The research of novel galanin receptor specific agonists and antagonists is also very promising for its future role in pharmacological treatment. The galaninergic system is important target for current and future biomedical research.

Language:

English

Rights:

http://creativecommons.org/publicdomain/mark/1.0/
policy:public

Source:

Physiological research | 2017 Volume:66 | Number:5

Harvested from:

CDK

Metadata only:

false